Limited and External Funding Opportunity Announcements

General guidelines for Limited Submissions


Active Internal Calls for Limited Submission Nominations 

NIH Neuroscience Blueprint

Internal submissions due February 20th.

A new funding opportunity is available through the NIH Neuroscience Blueprint for diverse neuroscience graduate students.  The award is designed to provide up to six years of support in two phases. The application deadline is April 8, 2017.

This is a great opportunity for outstanding PhD students completing their dissertation within the next 1-2 years who are interested in pursuing a career as an independent researcher. Eligibility is restricted to PhD students from underrepresented racial and ethnic groups or individuals with disabilities.

Please see the NIH website for additional eligibility requirements.

The Graduate School’s Office of Postdoctoral Affairs will be managing the university’s submission. Since this funding mechanism allows more than one applicant per institution, schools may submit multiple nominations. The Postdoctoral Advisory Committee will make final selections. Once selected, the Graduate School will coordinate application submission with nominees and their home departments/programs.    

If you are interested in this opportunity, please submit the attached information to Irene McKirgan no later than February 20th.   

Contact Irene McKirgan or Mark Wallace if you have any questions.


V Foundation 2017 Pediatric Cancer Translational Award

Internal submissions due March 1st.

Vanderbilt Ingram Cancer Center (VICC) has been invited to participate in The V Foundation 2017 Pediatric Cancer Translational Research Award. The Translational Research award is a $600,000 grant awarded in three annual installments of $200,000. 

VICC may nominate one candidate for this award. The single nominee may apply in either the V Scholar or the Translational program type for support.  This pediatric call is distinct from the V Foundation “all cancers” call for V Scholars and Translational awards (non-pediatric specific) which will have a separate invited call for applications. 

Please note: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial. We welcome applicants in all pediatric cancer types. While not required, we have a special interest in supporting immune oncology and immunotherapy research, when applicable.

Applicant Eligibility:  By the due date of the application, applicants who will lead this research team must have all the following:

  • Be scientists who hold a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
  • Applicants must be either US citizens or have a legal permit to work in the USA (either temporary or permanent).

V Foundation 2017 Pediatric Cancer V Scholar Award

Internal submissions due March 1st. 

The V Scholar Grant supports young tenure-track faculty to begin their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. The total amount of the grant is $200,000 awarded in two annual installments of $100,000, each.

Vanderbilt-Ingram Cancer Center (VICC) may nominate one applicant for the Pediatric Cancer V Scholar program. The single nominee may apply in either the V Scholar or the V Translational program type for support in this pediatric cancer research focused call for applications. Note: this pediatric call is distinct from the “all cancers” call for V Scholars and Translational awards (non-pediatric specific) which will have a separate invited call for applications.

Applicant Eligibility: All nominated applicants must meet all of the following criteria to be eligible to submit an application:

  • Must have at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for the specialty.
  • By the due date of the application, applicants must have all the following:
    • Hold a tenure-track faculty position as an assistant professor at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for this grant competition. 
    • Have been appointed to their first full-time assistant professor faculty position within the last 5 years, and not yet been promoted to associate professor.
    • Clinical scientists are eligible if VICC can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, start-up funds, and dedicated research time).
    • Applicants must be either US Citizens or permanent legal residents in the US. 
  • As of the due date of the application, applicants who have been awarded RO1 equivalent grants (project leader on an NIH multi-investigator grant, ACS) as principal investigators or as co-leader at the time of application submission are NOT eligible for consideration as a V Scholar. In addition, applicants cannot be a co-leader on a SPORE project or (co)PI of the following NIH grant mechanisms: U01, DP1, DP2, R37, R23. In addition, principal investigators for research project grants (RPGs), analogous to NIH/NCI R01 awards, would be ineligible.

V Foundation 2017 Translational Research Award

Internal submissions due March 1st.

Vanderbilt Ingram Cancer Center (VICC) has been invited to participate in The V Foundation 2017 Translational Research Award. The Translational Research award is a $600,000 grant awarded in three annual installments of $200,000. Indirect costs up to a maximum of 10% within the total award are permitted.

VICC may nominate two candidates for this award, if at least one of the two nominee applicants is submitting a research project that focuses on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in cancer causes, aggressiveness, treatment, or relapse.  Minorities for the purposes of this application are defined as African Americans or people of African descent, Pacific Islanders, Hispanic Americans, Native Americans, and Alaskan Natives. 

Any area of cancer research is permitted.  However, research on cancers that are more prevalent or aggressive in specific ethnic populations is encouraged, but not required. Cancers in which ethnic and racial disparities have previously been shown include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach, and liver.  As in 2016, among our highly ranked finalists for the 2017 Translational Award program, we will designate at least one of the highest ranked applications as the recipient of a Stuart Scott Memorial Fund Translational Research Award. While not required, we have a special interest in supporting immune oncology and immunotherapy research, when applicable.

Please note: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Applicant Eligibility:

By the due date of the application, applicants who will lead proposed research team must have all the following:

  • Be scientists who hold a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team. 
  • Applicants must be either US Citizens or have a legal permit to work in the USA (either temporary or permanent).

Active Internal Calls for NON-Limited External Nominations 

OREF/Musculoskeletal Tumor Society Clinical Research Grant in Orthopaedic Oncology (MSTS Clinical Research Grant)

Applications due February 20, 2017

OREF and the Musculoskeletal Tumor Society (MSTS) invite clinical researchers to apply for a Grant in the area of clinical orthopaedic oncology as part of a grant sharing program. The objective of the grant is to encourage new investigators by providing seed and start-up funding for promising research projects that improve clinical outcomes for patients.

Clinical projects are eligible, with clinical relevance explicitly and clearly described. Basic science proposals will not be considered. 

Criteria: 

  • Prospective clinical study involving multi-center collaboration.
  • Established infrastructure in place. 
  • MSTS clinical research priorities focus on randomized trials. 

Please visit the website for application details and instructions for submission.


Pancreatic Cancer Action Network (PANCAN) Early Detection Targeted Grant

Applications due February 22, 2017

This Request for Applications is to support ancillary research studies that identify promising blood biomarkers or imaging approaches that will eventually facilitate the use of specimens and/or participants in a cohort of new-onset diabetics and validate components of a protocol for the early detection of pancreatic ductal adenocarcinoma. Applicants may propose up to four Units, (or projects) with a specific goal and clearly defined, quantifiable outcome measures. 

Applicants may propose up to four Units, (or projects) with a specific goal and clearly defined, quantifiable outcome measures. Each Unit must indicate a separate budget, not to exceed $250,000, for a period of up to two years. The total amount requested may not exceed $1 million total for a total time period of four years.

Please visit the website for application details and instructions for submission. 


New York Stem Cell Foundation Awards

Applications due February 22, 2017

The 2017 NYSCF – Robertson Neuroscience Investigator Award and Stem Cell Investigator Award RFAs are now open. 

The awards provide $1.5M USD over 5 years and are open to researchers based at accredited academic institutions and nonprofit research institutions from throughout the world. An average of 3 awards in Neuroscience and 3 awards in Stem Cell are given annually. To see most recent award recipients, click here.

Neuroscience Awards: 

NYSCF is soliciting applications from early career investigators for Innovator awards in neuroscience. The goal of this initiative is to foster truly bold, innovative scientists with the potential to transform the field of neuroscience. Applicants are encouraged in the fundamental areas of developmental, cellular, cognitive, and translational neuroscience, broadly interpreted. Applicants need not be working in areas related to stem cells.

Stem Cell Awards: 

NYSCF is soliciting applications from early career investigators for Innovator Awards to be used for exploring the basic biology and translational potential of stem cells. The goal of this initiative is to foster bold and innovative scientists with the potential to transform the field of stem cell research, and advance understanding and use of stem cells in the development of treatments for human disease. In addition to providing funding, NYSCF partners with investigators to advance and translate their research.

Eligibility – candidates must:
• Have completed one or more of the following degrees: MD, PhD, DPhil
• Be within 5 years of starting a faculty (professorship) or comparable position on June 1, 2017
• Have demonstrated ability to independently supervise staff and research
• Have a publication record containing articles that are innovative and high impact

If you are interested in applying, please contact Adele White in the Office of Corporate & Foundation Relations for more information.


Innovator Awards for Postinfectious and Posthemorrhagic Hydrocephalus

LOIs due February 23, 2017.

The Hydrocephalus Association is soliciting applications for research on postinfectious and posthemorrhagic hydrocephalus. The goal of this initiative is to provide seed funding for bold and innovative research with the potential to transform the field of hydrocephalus through the understanding of disease mechanisms and the development of novel therapies and treatment approaches.

Postinfectious Hydrocephalus Focus Area:

  • The award provides short term seed funding for up to 12 months.
  • Proposals may be submitted for actual costs at one of two funding levels, $25,000 or $50,000.
  • Total funding is expected to be $200,000.

Posthemorrhagic Hydrocephalus Focus Area:

  • The award provides short term seed funding for up to 12 months.
  • Proposals may be submitted for actual costs at one of two funding levels, $25,000 or $50,000.
  • Total funding is expected to be $200,000.

Eligibility Criteria

To be eligible, candidates must:

  • Have a publication record containing articles that are innovative and high impact
  • Have demonstrated the ability to independently supervise staff and research
  • Have completed one or more of the following degrees: MD, PhD, DSc, DO, Pharm.D, or equivalent
  • Hold a research associate, assistant professorship, associate professorship, professorship, or any equivalent academic or non-academic position

PLEASE NOTE
Applicants must be members of the Hydrocephalus Association’s Network for Discovery Science. Creating a HANDS account is free; to do so, please visit the HANDS website.


AAAS Martin and Rose Wachtel Cancer Research Award

Applications due March 1, 2017. 

AAAS and Science Translational Medicine invite applications for the 2017 AAAS Martin and Rose Wachtel Cancer Research Award. Entrants must have received their Ph.D. or M.D. within the last 10 years. The award winner(s) are invited to deliver a public lecture on their research and receive a cash award of $25,000. The award-winning Essay(s) will be published in Science Translational Medicine.

The deadline for application is March 1, 2017.

Eligibility

  • Each entrant must be a researcher in the field of cancer, with an advanced degree (Ph.D., M.D., D.V.M.) received within the last 10 years. If the applicant has more than one advanced degree, the 10 years are counted from the date that all degrees were completed in the case of uninterrupted training, such as a dual degree M.D.-Ph.D. program. However, if the applicant completed one degree, left to do research or other activities (including residency or fellowship), and then returned to study for an additional degree, the 10 years are counted from the time of completion of the first advanced degree. Residency, fellowship, or postdoctoral training do not extend the timeline.
  • The research must have been performed during the previous 10 years.
  • The entrant must have performed or personally directed the work described in the Essay.
  • Applicants who did not win are welcome to reapply as long as they are otherwise eligible for the award. Previous winners and honorable mentions are not eligible to apply again.

Please visit the website for application details and instructions for submission.


Alzheimer's Association Clinical Fellowship (AACF) & Clinical Fellowship to Promote Diversity Program (AACF-D)

LOIs for each due March 6, 2017

The Association recognizes the need to support clinical research training in Alzheimer's and related dementias. For the purpose of this fellowship, clinical research is defined as patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research." Disease related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases. 

Areas of focus are high priority research areas in which the Association actively seeks proposals. The areas are defined broadly, and the examples cited are not intended to preclude or constrain other projects or proposals. Potential applicants are strongly encouraged to submit proposals in their own areas of interest or formulate questions different from those presented in this announcement. Innovative and novel ideas to address challenges in research are the core of the Association`s scientific program. 

  • Research in Diverse Populations: Closing the Gap 
  • Social and behavioral research has the potential to increase our understanding of the effects of Alzheimer's disease and other dementias on individuals with the disease, their families and other caregivers. 
  • Biological Focus: Causes, Early Detection, Treatment, Models, Prevention and Risk Factors. 

Please visit the website for application details and instructions for submission.


The Science & PINS Prize for Neuromodulation

​Applications due March 15, 2017 

The Science & PINS Prize for Neuromodulation is a highly competitive prize which honors scientists for their excellent contributions to neuromodulation research.  Neuromodulation is any form of alteration of nerve activity through the delivery of physical (electrical, magnetic, optical) stimulation or chemical agents to targeted sites of the body. Established in 2016, the prize is awarded annually for outstanding research as described in a 1,500 word essay based on research performed in the past three years.

The winner of the Science & PINS Prize for Neuromodulation is awarded $25,000 and publication of his or her essay in Science. The Grand Prize essay and that of the Runner-up are also published on Science Online. The award is announced and presented at a ceremony in September 2017. PINS will provide financial support to help enable the grand prize winner to attend the ceremony.

Please visit the website for application details and instructions for submission.


Harold Amos Medical Faculty Development Program Scholars

​Applications due March 15, 2017 

Applications are now open for the 2017 cohort of Harold Amos Medical Faculty Development Program Scholars. This program works to increase diversity among medical, nursing, and dentistry faculty.   

Up to 10 selected program scholars are eligible for:

A four-year postdoctoral award of up to $420,000
An annual stipend of $75,000
An annual grant of $30,000 to support research
Additional awards available through partnership organizations

Supported by the Robert Wood Johnson Foundation—and a desire to build a Culture of Health in America—the Harold Amos program acts on the belief that an ever-changing health care landscape requires capable, diverse leadership. We strongly encourage applicants from “historically disadvantaged backgrounds,” which refers to challenges individuals may have faced because of their race, ethnicity, socioeconomic status, physical, learning or other disability, or who are first-generation college graduates.

Please visit the website for application details and instructions for submission.


Alliance for Cancer Gene Therapy (ACGT)'s 2017 Investigator's Award in Clinical Translation of Cell and Gene Therapies for Cancer​

LOIs due March 21, 2017

The Fund for Advancement award grants $500,000 to Principal Investigators conducting translational research that will move cell and gene therapies from the laboratory towards clinical trials.

Eligibility:

Candidates must hold an MD, PhD, or equivalent degree and be a tenure-track or tenured faculty. The investigator must be conducting original research as an independent faculty member. ACGT has no citizenship restrictions; however, research supported by the award must be conducted at medical schools and research centers in the United States and Canada. Entering into clinical translation during the funding period is a requirement. Continued support is contingent upon submission and approval of a non-competitive renewal application each year.

Please visit the website for application details and instructions for submission.


The Franklin Institute Bower Award and Prize for Achievement in Science

Applications due May 31, 2017

Theme: Genome Editing

Prize: $250,000 

The Franklin Institute seeks nominations for the 2018 Bower Award and Prize for Achievement in Science of individuals who have made significant contributions to our understanding or the development of genome editing and/or its applications. Nominations may recognize contributions including, but not limited to, the discovery/elucidation of genome editing mechanisms such as those involving CRISPR, TALENs, or zinc finger nucleases; genome editing tool development; or genome editing for basic research or applied outcomes in a variety of systems (e.g. for crop improvement or medical therapeutics). Nominations must clearly indicate the scientific impact of the nominee’s work, whether conceptual, technical, or integrative.

Eligibility:

  • This is an international competition for individuals who have made significant contributions to our understanding or the development of genome editing and/or its applications.
  • This award and prize must be presented to an individual, as specified by the will of Henry Bower.
  • Candidates must be living, and the winner must participate in The Franklin Institute Awards Week programs, to be held in April 2018 in Philadelphia, Pennsylvania, USA.
  • Self-nominations are accepted.

Please visit the website for application details and instructions for submission.


Eppendorf & Science Prize for Neurobiology

Applications due June 15, 2017

The Prize is awarded annually to one young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted by him/her during the past three years.

Prize money: $25,000

Rules of Eligibility

  • Entrants must be a neurobiologist with an advanced degree received in the last 10 years and not older than 35 years of age.
  • The entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology.
  • The entrant must have performed or directed the work described in the essay.
  • The research must have been performed during the previous three years.

Please visit the website for application details and instructions for submission.


Walmart Foundation National Giving Program

LOIs reviewed on an ongoing basis. There are no deadlines.

The underlying focus in all of the Walmart Foundation's work is on empowering low-income people to help them live better. This program allows the Foundation to work strategically with organizations working across one or more states to address social issues strongly aligned with the Foundation's focus areas. 

The program awards grants of $250,000 and above. Overhead/indirect costs (i.e., non-program-related expenses) may not exceed 10% of the total program budget. Walmart and the Walmart Foundation do not currently award multi-year commitments. Organizations may, however, propose initiatives with timeframes that extend up to two years. No-cost extensions may be requested for up to an additional 12 months, if necessary. 

Please visit the website for application details and instructions for submission.